Tang Yong Qun - Net Worth and Insider Trading

Tang Yong Qun Net Worth

The estimated net worth of Tang Yong Qun is at least $3.9 Billion dollars as of 2024-06-24. Tang Yong Qun is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd and owns about 319,885,249 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) stock worth over $3.9 Billion. Details can be seen in Tang Yong Qun's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tang Yong Qun has not made any transactions after 2022-07-11 and currently still holds the listed stock(s).

Transaction Summary of Tang Yong Qun

To

Tang Yong Qun Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tang Yong Qun owns 1 companies in total, including Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) .

Click here to see the complete history of Tang Yong Qun’s form 4 insider trades.

Insider Ownership Summary of Tang Yong Qun

Ticker Comapny Transaction Date Type of Owner
SHSE:603707 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd 2022-07-11 Director

Tang Yong Qun Latest Holdings Summary

Tang Yong Qun currently owns a total of 1 stock. Tang Yong Qun owns 319,885,249 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) as of July 11, 2022, with a value of $3.9 Billion.

Latest Holdings of Tang Yong Qun

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SHSE:603707 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd 2022-07-11 319,885,249 12.12 3,877,009,218

Holding Weightings of Tang Yong Qun


Tang Yong Qun Form 4 Trading Tracker

According to the SEC Form 4 filings, Tang Yong Qun has made a total of 2 transactions in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Nanjing King-Friend Biochemical Pharmaceutical Co Ltd is the sale of 73,819,673 shares on July 11, 2022, which brought Tang Yong Qun around $0.

Insider Trading History of Tang Yong Qun

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tang Yong Qun Trading Performance

GuruFocus tracks the stock performance after each of Tang Yong Qun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tang Yong Qun is 1.42%. GuruFocus also compares Tang Yong Qun's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tang Yong Qun within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tang Yong Qun's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tang Yong Qun

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.92 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.81 LIMIT LIMIT LIMIT LIMIT LIMIT

Tang Yong Qun Ownership Network

Ownership Network List of Tang Yong Qun

No Data

Ownership Network Relation of Tang Yong Qun

Insider Network Chart

Tang Yong Qun Owned Company Details

What does Nanjing King-Friend Biochemical Pharmaceutical Co Ltd do?

Who are the key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd?

Tang Yong Qun is the Director of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd. Other key executives at Nanjing King-Friend Biochemical Pharmaceutical Co Ltd include Supervisors Liu Zu Qing , senior management Wu Gui Ping , and senior management Qian Xiao Jie .

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd (SHSE:603707)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Insider Transactions

No Available Data

Tang Yong Qun Mailing Address

Above is the net worth, insider trading, and ownership report for Tang Yong Qun. Currently GuruFocus does not have mailing address information for Tang Yong Qun.

Discussions on Tang Yong Qun

No discussions yet.